Rosuvastatin elicits KDR-dependent vasculogenic response of human placental stem cells through PI3K/AKT pathway-Reference-Cited by-同舟云学术

Rosuvastatin elicits KDR-dependent vasculogenic response of human placental stem cells through PI3K/AKT pathway

Published:2012-03 Issue:3 Volume:65 Page:275-284
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Cantoni Silvia,Cavallini Claudia,Bianchi Francesca,Bonavita Francesca,Vaccari Valentina,Olivi Elena,Frascari Irene,Tassinari Riccardo,Valente Sabrina,Lionetti Vincenzo,Ventura Carlo

Publisher

Elsevier BV

Subject

Pharmacology

Reference37 articles.

1. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond lowdensity lipoprotein cholesterol;Liao;Am J Cardiol,2005

2. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals;Kureishi;Nat Med,2000

3. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells;Llevadot;J Clin Invest,2001

4. High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling – results from a randomized, double-blind, and placebo-controlled study;Erbs;Int J Cardiol,2011

5. Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel signature of the ligand and receptor genes associated with disulfidoptosis for prediction of prognosis, immunologic therapy responses in hepatocellular carcinoma;Heliyon;2023-09

2. Effect of Atorvastatin on Angiogenesis-Related Genes VEGF-A, HGF and IGF-1 and the Modulation of PI3K/AKT/mTOR Transcripts in Bone-Marrow-Derived Mesenchymal Stem Cells;Current Issues in Molecular Biology;2023-03-10

3. Endothelial progenitor cells in the host defense response;Pharmacology & Therapeutics;2023-01

4. Ranolazine rescues the heart failure phenotype of PLN-deficient human pluripotent stem cell-derived cardiomyocytes;Stem Cell Reports;2022-04

5. Anti-inflammatory and immunomodulatory effects of rosuvastatin in patients with low-to-moderate cardiovascular risk;Acta Pharmaceutica;2021-12-30